x

Search for a clinical trial

* (*) mandatory field

23 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

FRANCE

AUVERGNE-RHONE-ALPES
LYON

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Phase 2 single-arm study of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors - Terminated -
CLCC Institut Gustave Roussy
Département de cancérologie de l'enfant et de l'adolescent

GERMANY

Baden-Württemberg
HEIDELBERG

Recruiting trial
Ongoing trial
Phase I/II therapy trial to determine the safety and efficacy of heavy Ion Radiotherapy in patients with Osteosarcoma - DE
Neurologische Universitätsklinik Heidelberg
Klinik für Radioonkologie und Strahlentherapie

GERMANY

Baden-Württemberg
STUTTGART

Ongoing trial
EURO-B.O.S.S.: A European treatment protocol for bone sarcoma in patients older than 40 years - DE
Klinikum Stuttgart - Standort Olgahospital
COSS (Cooperative OsteoSarkom Studiengruppe) Studienzentrale

SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Phase II multicentric and prospective trial with gemcitabine and rapamycin in second line of metastatic osteosarcoma - ES (completed)
Hospital Universitari Sant Joan de Déu
Área clínica de Oncohematología Pediátrica

SPAIN

Madrid
MADRID

Recruiting trial
Ongoing trial
Phase 1/2 Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies - ES
Hospital Infantil Universitario Niño Jesús
Servicio de Oncohematología

NETHERLANDS

Zuid-Holland
LEIDEN

Recruiting trial
Ongoing trial
Adjuvant Zoledronic Acid in 'High Risk' Giant Cell Tumour of Bone (GCT) - A Randomized Phase II Study
LUMC - Leids Universitair Medisch Centrum
Afdeling Klinische Oncologie

UNITED KINGDOM

Greater Manchester
NOT YET IDENTIFIED - UK

Multinational clinical trial(s)